• Clodronate Liposomes: Precision In Vivo Macrophage Depletion

  2026-05-19

  Clodronate Liposomes enable highly selective, reproducible in vivo macrophage depletion, unlocking advanced immune modulation and insight into disease mechanisms. This guide translates recent breakthroughs into actionable protocols and troubleshooting strategies, with workflow enhancements informed by cutting-edge single-cell and polarization research.

• Losmapimod (SKU B4620): Reliable p38 MAPK Inhibition for Cel

  2026-05-19

  This article guides biomedical researchers through practical laboratory scenarios where Losmapimod (SKU B4620) offers robust, data-backed solutions for cell viability, proliferation, and cytotoxicity assays. Grounded in recent structural and mechanistic insights, the discussion highlights how Losmapimod's dual-action inhibition of p38 MAPK advances reproducibility and experimental clarity. Protocol parameters and product selection advice help ensure optimal assay performance.

• Monomeric Amyloid Beta Modulates Microglial Inflammation via

  2026-05-18

  Kwon et al. reveal that monomeric amyloid beta, a cleavage product of APP, acts as a negative regulator of microglial inflammatory activation through an APP/heterotrimeric G protein-mediated pathway. This finding challenges the conventional view of amyloid beta solely as a pathogenic agent and highlights its potential physiological role in maintaining brain immune homeostasis during cortical development.

• MK-2206 dihydrochloride: Advanced Workflows in Cancer Resear

  2026-05-18

  MK-2206 dihydrochloride empowers researchers to dissect the PI3K/Akt/mTOR axis with precision, driving breakthroughs in cancer cell apoptosis and pathway modulation. Its robust solubility profile and validated efficacy in apoptosis assays make it indispensable for studies targeting signaling-driven angiogenesis, as exemplified by recent advances in hepatocellular carcinoma research.

• Leucovorin Calcium in Tumor Assembloid Research: Best Practi

  2026-05-17

  Leucovorin Calcium transforms gastric cancer research by enabling precise modulation of antifolate responses in complex assembloid models. This article unpacks actionable workflows, troubleshooting strategies, and comparative insights that set APExBIO’s solution apart in advanced tumor microenvironment studies.

• Repurposing Novobiocin: In Vitro Activity Against SFTSV

  2026-05-16

  This article reviews new findings on Novobiocin, an aminocoumarin antibiotic, identified for in vitro antiviral activity against severe fever with thrombocytopenia syndrome virus (SFTSV). The study demonstrates its potential for drug repurposing in emerging viral infections, with mechanistic and translational insights for researchers.

• Reliable Wnt Pathway Activation: Best Practices with Wnt Ago

  2026-05-15

  This article offers scenario-driven, evidence-based guidance for biomedical researchers using Wnt agonist 1 (SKU B6059) in cell viability, proliferation, and differentiation assays. It highlights reproducibility, mechanistic depth, and vendor reliability—grounded in primary literature and APExBIO’s high-purity supply—to enable robust Wnt pathway research.

• Exercise-Evoked Muscle EVs Enhance Amyloid Clearance in AD M

  2026-05-15

  A recent study demonstrates that swimming exercise in Alzheimer's disease (AD) mouse models increases skeletal muscle-derived extracellular vesicles (SKM-EVs), which are taken up by microglia to promote amyloid-beta plaque clearance. This mechanistic insight reveals a novel pathway for exercise-induced cognitive benefits in AD and suggests new targets for therapeutic intervention.

• Miltefosine (SKU B1371): Data-Driven Solutions for Hematolog

  2026-05-14

  This article addresses common laboratory challenges in cell viability, proliferation, and cytotoxicity assays, demonstrating how Miltefosine (SKU B1371) delivers reliable, reproducible results. Drawing on recent mechanistic evidence and protocol optimizations, we highlight how Miltefosine’s dual PI3K/Akt inhibition and Ras/MEK/ERK activation make it a superior choice for translational research in hematology and oncology.

• Cell Surface Integrity as a Limiting Factor for Yeast Ploidy

  2026-05-14

  This article reviews a recent study demonstrating that cell surface integrity fundamentally limits the maximum ploidy attainable in budding yeast. By employing two independent approaches to induce polyploidy, the researchers show that alleviating membrane stress allows for higher ploidy, while increased stress restricts it. These findings offer new insights into the interplay between genome duplication, cell size, and membrane physiology, with important implications for fungal biology and antifungal research.

• BjuBRC1-1 Represses Flowering in Brassica juncea via BjuFUL

  2026-05-13

  Feng et al. (2022) reveal that the transcription factor BjuBRC1-1, induced under short-day conditions, acts as a negative regulator of flowering in Brassica juncea by directly binding the promoter of BjuFUL. These insights clarify the genetic network modulating flowering time and provide a foundation for manipulating flowering in crop breeding.

• rTMS-Induced Cognitive Recovery in AD via Cx3cl1-Cx3cr1 Axis

  2026-05-13

  This study uncovers the molecular mechanism by which repetitive transcranial magnetic stimulation (rTMS) promotes cognitive recovery in Alzheimer's disease through GABAergic neuron activation and enhanced Cx3cl1-Cx3cr1 signaling. The findings highlight a non-invasive therapeutic avenue that improves microglial amyloid clearance and reduces neuroinflammation, providing a foundation for translational AD research.

• Thiamet G: Selective O-GlcNAcase Inhibitor for O-GlcNAc Rese

  2026-05-12

  Thiamet G is a potent O-GlcNAcase inhibitor that elevates cellular O-GlcNAcylation and modulates key disease pathways. It has nanomolar potency and demonstrated neuroprotective effects. This dossier provides verifiable facts, protocol guidance, and critical boundaries to support translational research.

• LY-411575: Redefining Translational Targets in Alzheimer’s a

  2026-05-12

  This thought-leadership article explores how the potent gamma-secretase inhibitor LY-411575 is at the vanguard of translational research, bridging Alzheimer’s disease and cancer biology. Integrating recent mechanistic insights—especially from immuno-oncology breakthroughs—this piece delivers actionable guidance for researchers seeking to maximize the impact of pathway-targeted interventions, with evidence-based recommendations, protocol parameters, and a critical analysis of the evolving landscape.

• DAPT (GSI-IX): Reliable γ-Secretase Inhibition for Cell Assa

  2026-05-11

  This article addresses key challenges in cell viability, proliferation, and cytotoxicity assays by providing scenario-based guidance on DAPT (GSI-IX) (SKU A8200). Integrating quantitative evidence, practical protocol insights, and product selection advice, it demonstrates how APExBIO's DAPT (GSI-IX) ensures reproducibility and workflow compatibility for Notch signaling studies.

405 records 8/27 page Previous Next First page 上5页 678910 下5页 Last page